Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30058074

NC(=O)c1ccc2c(c1)CCCN2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.65
▸ MAPT P10636 2/20 0.65
▸ GAA P10253 2/20 0.47
▸ NNMT P40261 2/20 0.47
▸ PLAU P00749 1/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ ACHE P22303 4/20 0.44
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ MASP2 O00187 1/20 0.41
▸ F2 P00734 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29779525 0.92 KDM4E (0.52) KDM4EMAPTGAANNMTPLAU
SCHEMBL12486871 0.90 KDM4E (0.73) KDM4EMAPTGAANNMTPLAU
SCHEMBL30011603 0.90 KDM4E (0.73) KDM4EMAPTGAANNMTPLAU
SCHEMBL6137536 0.86 KDM4E (0.67) KDM4EMAPTGAANNMTPLAU
SCHEMBL4051485 0.81 KDM4E (0.58) KDM4EMAPTNNMTPLAUCA12
SCHEMBL29779540 0.81 KDM4E (0.58) KDM4EMAPTNNMTPLAUCA12
Trifluoroacetic Acid SCHEMBL7423059 0.80 ALDH1A1 (0.54) MAPTALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL8141928 0.80 ALDH1A1 (0.59) MAPTGAAPLAUALDH1A1LMNA
SCHEMBL19691206 0.79 KDM4E (0.57) KDM4EMAPTNNMTPLAUCA12
SCHEMBL45202 0.79 KDM4E (1.00) KDM4EMAPTGAANNMTPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434472-B2 Agent for removing undifferentiated iPS cells Sumitomo Pharma Co., Ltd. (JP) 2022-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434472-B2 Agent for removing undifferentiated iPS cells SALL4, NR4A2, NES KDM4E 304/4885MAPT 4069/4885GAA 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback